Skip to content

Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 Diabetes

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00396851
Enrollment
100
Registered
2006-11-08
Start date
2007-01-31
Completion date
Unknown
Last updated
2006-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Brief summary

The study plans to compare the glucose-lowering effect of gurmar, a herbal preparation, with metformin in patients with type 2 diabetes

Interventions

DRUGGurmar
DRUGMetformin

Sponsors

Indian Council of Medical Research
CollaboratorOTHER_GOV
International Clinical Epidemiology Network (INCLEN) TRUST
CollaboratorNETWORK
Post Graduate Institute of Medical Education and Research, Chandigarh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
25 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Newly detected type 2 diabetes * Fasting plasma glucose \>126mg/dl * HbA1c \> 7%

Exclusion criteria

* Serious comorbid illnesss * History of drug abuse * History of recent weight loss

Countries

India

Contacts

Primary ContactSamir Malhotra, MD, DM
samirmalhotra345@yahoo.com+91-172-27552433

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026